Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2025-12-25 @ 12:45 AM
NCT ID: NCT02295267
Eligibility Criteria: Inclusion Criteria: * Signed informed consent * Group A: positive case history of allergic reaction(s) to walnut * Group B: positive case history of allergy to birch, grass or olive pollen and no case history of allergic reaction(s) to walnut * Group C: no case history of atopic disease Exclusion Criteria: * Known pregnancy * Breast-feeding of infant * Treatment with the following drugs (or shortest interval between last treatment and food challenge or SPT): * corticosteroids (2 weeks): applied systemically, to the nose or locally on the skin test area. * antihistamines (3 days) except hydroxyzine (10 days) * betablocker agents (1 day) * angiotensin converting enzyme inhibitors (2 days) * Any major organic or infectious disease
Healthy Volunteers: True
Sex: ALL
Minimum Age: 1 Year
Maximum Age: 70 Years
Study: NCT02295267
Study Brief:
Protocol Section: NCT02295267